$34.31
-0.12[-0.35%]
At close: May 17
$34.31
0[0.00%]
After Hours: 4:00PM EDT
Genpact Stock (NYSE:G), Analyst Ratings, Price Targets, Predictions
Genpact Ltd has a consensus price target of $41, established from looking at the 37 latest analyst ratings. The last 3 analyst ratings were released from BMO Capital, Wedbush, and Needham on May 10, 2024. With an average price target of $37.67 between BMO Capital, Wedbush, and Needham, there's an implied 9.78% upside for Genpact Ltd from these 3 analyst ratings.
Analyst Firms Making Recommendations1
BMO Capital
Wedbush
Needham
Citigroup
JP Morgan
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Genpact
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/10/2024 | Buy Now | 10.75% | BMO Capital | Keith Bachman | $39 → $38 | Maintains | Market Perform | Get Alert |
| 05/10/2024 | Buy Now | 2.01% | Wedbush | Moshe Katri | → $35 | Reiterates | Neutral → Neutral | Get Alert |
| 05/10/2024 | Buy Now | 16.58% | Needham | Mayank Tandon | → $40 | Reiterates | Buy → Buy | Get Alert |
| 04/22/2024 | Buy Now | -3.82% | Citigroup | Ashwin Shirvaikar | $36 → $33 | Maintains | Neutral | Get Alert |
| 02/09/2024 | Buy Now | 25.33% | JP Morgan | Tien-Tsin Huang | $42 → $43 | Maintains | Underweight | Get Alert |
| 02/09/2024 | Buy Now | 16.58% | Needham | Mayank Tandon | → $40 | Reiterates | Buy → Buy | Get Alert |
| 01/30/2024 | Buy Now | 16.58% | Mizuho | Dan Dolev | → $40 | Initiates | → Neutral | Get Alert |
| 01/17/2024 | Buy Now | 4.93% | Citigroup | Ashwin Shirvaikar | $35 → $36 | Maintains | Neutral | Get Alert |
| 12/15/2023 | Buy Now | 10.75% | Baird | David Koning | → $38 | Downgrade | Outperform → Neutral | Get Alert |
| 11/09/2023 | Buy Now | 16.58% | Needham | Mayank Tandon | $50 → $40 | Maintains | Buy | Get Alert |
| 08/22/2023 | Buy Now | 16.58% | JP Morgan | Tien-Tsin Huang | → $40 | Downgrade | Neutral → Underweight | Get Alert |
| 08/11/2023 | Buy Now | 45.73% | Needham | Mayank Tandon | $56 → $50 | Maintains | Buy | Get Alert |
| 08/10/2023 | Buy Now | 16.58% | JP Morgan | Tien-Tsin Huang | $46 → $40 | Maintains | Neutral | Get Alert |
| 08/10/2023 | Buy Now | 31.16% | Wedbush | Moshe Katri | → $45 | Reiterates | Neutral → Neutral | Get Alert |
| 08/10/2023 | Buy Now | 19.5% | BMO Capital | Keith Bachman | $46 → $41 | Maintains | Market Perform | Get Alert |
| 07/18/2023 | Buy Now | 22.41% | Citigroup | Ashwin Shirvaikar | $46 → $42 | Downgrade | Buy → Neutral | Get Alert |
| 06/07/2023 | Buy Now | 31.16% | Wedbush | Moshe Katri | → $45 | Reiterates | Neutral → Neutral | Get Alert |
| 05/15/2023 | Buy Now | 19.5% | Jefferies | Surinder Thind | $47 → $41 | Maintains | Hold | Get Alert |
| 05/11/2023 | Buy Now | 34.07% | BMO Capital | Keith Bachman | $53 → $46 | Maintains | Market Perform | Get Alert |
| 05/11/2023 | Buy Now | 28.24% | TD Cowen | Bryan Bergin | $48 → $44 | Maintains | Market Perform | Get Alert |
| 05/11/2023 | Buy Now | 39.9% | Baird | David Koning | $54 → $48 | Maintains | Outperform | Get Alert |
| 05/11/2023 | Buy Now | 63.22% | Needham | Mayank Tandon | → $56 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | Buy Now | 34.07% | Citigroup | Ashwin Shirvaikar | $54 → $46 | Maintains | Buy | Get Alert |
| 02/13/2023 | Buy Now | 57.39% | Citigroup | Ashwin Shirvaikar | $52 → $54 | Maintains | Buy | Get Alert |
| 02/10/2023 | Buy Now | 63.22% | Needham | Mayank Tandon | → $56 | Reiterates | → Buy | Get Alert |
| 02/08/2023 | Buy Now | 54.47% | BMO Capital | Keith Bachman | $51 → $53 | Maintains | Market Perform | Get Alert |
| 12/15/2022 | Buy Now | 45.73% | JP Morgan | Tien-Tsin Huang | $55 → $50 | Downgrade | Overweight → Neutral | Get Alert |
| 11/10/2022 | Buy Now | 48.64% | BMO Capital | Keith Bachman | $57 → $51 | Maintains | Market Perform | Get Alert |
| 11/10/2022 | Buy Now | 51.56% | Citigroup | Ashwin Shirvaikar | $56 → $52 | Maintains | Buy | Get Alert |
| 10/14/2022 | Buy Now | 60.3% | JP Morgan | Tien-Tsin Huang | $62 → $55 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Genpact (G)?
The latest price target for Genpact (NYSE: G) was reported by BMO Capital on May 10, 2024. The analyst firm set a price target for $38.00 expecting G to rise to within 12 months (a possible 10.75% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Genpact (G)?
The latest analyst rating for Genpact (NYSE: G) was provided by BMO Capital, and Genpact maintained their market perform rating.
When was the last upgrade for Genpact (G)?
There is no last upgrade for Genpact.
When was the last downgrade for Genpact (G)?
The last downgrade for Genpact Ltd happened on December 15, 2023 when Baird changed their price target from N/A to $38 for Genpact Ltd.
When is the next analyst rating going to be posted or updated for Genpact (G)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genpact, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genpact was filed on May 10, 2024 so you should expect the next rating to be made available sometime around May 10, 2025.
Is the Analyst Rating Genpact (G) correct?
While ratings are subjective and will change, the latest Genpact (G) rating was a maintained with a price target of $39.00 to $38.00. The current price Genpact (G) is trading at is $34.31, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.